| |
| |
|
| Insider
Information: |
Gianakakos Anastasios |
| Relationship: |
Director |
| City: |
Mountain View |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
53,630 |
|
|
Indirect Shares
|
309,623 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
363,253 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
1
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
2.0
|
| Percentage
Gain/Loss : |
 38.5%
|
115.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Map Pharmaceuticals Inc |
MAPP |
SVP, Chief Business Of... |
2013-03-01 |
0 |
2008-05-15 |
0 |
Premium* |
|
|
Lianbio |
LIAN |
Director |
2024-02-15 |
53,630 |
2024-02-15 |
309,623 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LIAN |
Lianbio |
Director |
– • – |
2024-02-15 |
4 |
D |
$4.76 |
$91,478 |
D/D |
(19,218) |
53,630 |
0 |
- |
|
| LIAN |
Lianbio |
Director |
– • – |
2024-02-15 |
4 |
OE |
$2.52 |
$91,476 |
D/D |
36,300 |
72,848 |
0 |
- |
|
| LIAN |
Lianbio |
Director |
– • – |
2021-12-29 |
4 |
OE |
$6.49 |
$237,197 |
D/D |
36,548 |
36,548 |
0 |
- |
|
| LIAN |
Lianbio |
Director |
– • – |
2021-10-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
309,623 |
|
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Business Officer |
• – – |
2013-03-01 |
4 |
D |
$25.00 |
$460,950 |
D/D |
(18,438) |
0 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Business Officer |
• – – |
2013-02-28 |
4 |
AS |
$25.00 |
$500,000 |
D/D |
(20,000) |
18,438 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Business Officer |
• – – |
2013-02-28 |
4 |
OE |
$10.37 |
$207,400 |
D/D |
20,000 |
38,438 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Business Officer |
• – – |
2013-01-26 |
4 |
D |
$24.75 |
$20,939 |
D/D |
(846) |
17,450 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Business Officer |
• – – |
2013-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,250 |
18,296 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Business Officer |
• – – |
2013-01-25 |
4 |
D |
$24.75 |
$25,592 |
D/D |
(1,034) |
16,046 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Business Officer |
• – – |
2013-01-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,750 |
17,080 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Business Officer |
• – – |
2013-01-23 |
4 |
AS |
$24.76 |
$742,800 |
D/D |
(30,000) |
14,330 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Business Officer |
• – – |
2013-01-23 |
4 |
OE |
$10.37 |
$311,100 |
D/D |
30,000 |
44,330 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Business Officer |
• – – |
2012-11-20 |
5 |
A |
$9.89 |
$2,196 |
D/D |
222 |
14,330 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Business Officer |
• – – |
2012-11-01 |
4 |
OE |
$6.39 |
$36,849 |
D/D |
5,767 |
18,152 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Business Officer |
• – – |
2012-11-01 |
4 |
AS |
$15.64 |
$90,203 |
D/D |
(5,767) |
12,385 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Business Officer |
• – – |
2012-05-20 |
5 |
A |
$9.81 |
$16,901 |
D/D |
1,723 |
14,108 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Business Officer |
• – – |
2012-04-02 |
4 |
AS |
$14.38 |
$35,947 |
D/D |
(2,500) |
12,385 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Business Officer |
• – – |
2012-04-02 |
4 |
OE |
$6.39 |
$15,974 |
D/D |
2,500 |
14,885 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP & Chief Business Officer |
• – – |
2012-02-21 |
4 |
AS |
$15.99 |
$40,017 |
D/D |
(2,500) |
12,385 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP & Chief Business Officer |
• – – |
2012-02-21 |
4 |
OE |
$6.39 |
$15,974 |
D/D |
2,500 |
13,770 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP & Chief Business Officer |
• – – |
2012-02-06 |
4 |
OE |
$6.39 |
$63,897 |
D/D |
10,000 |
22,385 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP & Chief Business Officer |
• – – |
2012-02-06 |
4 |
AS |
$15.00 |
$150,000 |
D/D |
(10,000) |
12,385 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP & Chief Business Officer |
• – – |
2012-01-26 |
4 |
D |
$13.84 |
$13,051 |
D/D |
(943) |
12,385 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP & Chief Business Officer |
• – – |
2012-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,250 |
13,328 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
